Search - tctmd.com

Displaying 1 - 20 of 74

Sort: Relevancy | Date

Presentation TCT 2024

TCT 911: Vascular Disease in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: From Incidence to Clinical Outcomes

Presenter: Gijs Broeze

October 29, 2024

Presentation TCT 2024

TCT 906: Facilitated Transfemoral Versus Alternative Access Transcatheter Aortic Valve Replacement in Patients With Peripheral Vascular Disease: Intra-Procedural and 30-Day Outcomes

Presenter: M. Abubakar Shakir

October 29, 2024

Presentation TCT 2024

TCT 897: Experience Using Brachiocephalic TAVI Access as an Alternative Option for Patients Unsuitable for Transfemoral or Left Subclavian Approach: A Two-Centre Series

Presenter: Hani Muradagha

October 28, 2024

Presentation TCT 2024

TCT 1395: Transfemoral Approach of TAVR in Patients With Prior Aortic Dissection: Two Case Studies

Presenter: ashrith garimella

October 28, 2024

Presentation TCT 2024

TCT 163: Self-Expandable Versus Balloon-Expandable Valves in Patients With Small Annuli Undergoing Transfemoral Transcatheter Aortic Valve Implantation

Presenter: Kimberley Hemelrijk

October 28, 2024

Presentation TCT 2024

TCT 153: Surgical Bailout in Transfemoral Transcatheter Aortic Valve Replacement: Insights From a Contemporary TAVR Cohort During the COVID-19 Pandemic

Presenter: Hugo Aarts

October 28, 2024

Presentation NY Valves 2024

Transfemoral TAVI With Dedicated Device for Severe Aortic Regurgitation in Patient With Left Ventricular Assist Device With Aortic Cusp Thrombus

Presenter: Simon Lam

June 06, 2024

Presentation NY Valves 2024

IVUS-Directed Transfemoral Balloon Expandable TAVR in Pure Aortic Regurgitation Through an Endograft With Residual Aortic Dissection

Presenter: Arianna Favela

June 06, 2024

Presentation TCT 2023

TCT 705: Feasibility, Safety and Impact on Vascular Complication Management of Radial Use as an Ancillary Access During Transfemoral Transcatheter Aortic Valve Replacement: the TAVI-LITE Experience

Presenter: Enrico Romagnoli

October 26, 2023

Presentation TCT 2023

TCT 113: (Pre)clinical Case Studies of J-Valve Transfemoral System for Treating Large Annulus Aortic Regurgitation

Presenter: Dongming Hou

October 24, 2023

Presentation TCT 2022

TCT 791: Concomitant transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve-in-ring (TMViR) procedure with transfemoral approach

Presenter: Smitha Narayana Gowda

September 17, 2022

Presentation TVT 2022

Transcarotid Versus Transfemoral TAVR: Propensity-Matched Analysis of In-Hospital and 1-Year Clinical Outcomes

Presenter: Hossein Ouranos

June 09, 2022

Presentation TVT 2022

Intravascular Lithotripsy Assisted Percutaneous Transfemoral TAVR with Direct Puncture and Closure of Femoral Dacron Graft in a Nonagenarian with Prior Aortic Stent Graft

Presenter: Tanush Gupta

June 09, 2022

Presentation TCT 2020

TCT 612: Apical VSD and Left Ventricular Dissection Following Transfemoral Transcatheter Aortic Valve Replacement

Presenter: Malik Shehadeh

October 14, 2020

Presentation TCT 2020

TCT 485: Do Manufacturer's Derived Recommendations Predict Vascular Complications During Transfemoral TAVI Approaches Using Default Proglide Strategy?

Presenter: Beytullah Çakal

October 14, 2020

Presentation TCT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation

Presenter: Vinod Thourani

September 27, 2019

Presentation TCT 2019

The Anatomically “Correct” Transfemoral JenaValve TAVR System

Presenter: Hendrik Treede

September 27, 2019

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 15, 2019

Presentation TVT 2019

New Generation Transcatheter Heart Valve for Severe Non-Calcified Aortic Regurgitation – The Transfemoral J-Valve System

Presenter: Mark Hensey

June 14, 2019

Presentation TVT 2019

Illustrative Cases

Presenter: Michael Reardon

June 13, 2019

Advertisement

TCT 911: Vascular Disease in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement: From Incidence to Clinical Outcomes

TCT 906: Facilitated Transfemoral Versus Alternative Access Transcatheter Aortic Valve Replacement in Patients With Peripheral Vascular Disease: Intra-Procedural and 30-Day Outcomes

TCT 897: Experience Using Brachiocephalic TAVI Access as an Alternative Option for Patients Unsuitable for Transfemoral or Left Subclavian Approach: A Two-Centre Series

TCT 1395: Transfemoral Approach of TAVR in Patients With Prior Aortic Dissection: Two Case Studies

TCT 163: Self-Expandable Versus Balloon-Expandable Valves in Patients With Small Annuli Undergoing Transfemoral Transcatheter Aortic Valve Implantation

TCT 153: Surgical Bailout in Transfemoral Transcatheter Aortic Valve Replacement: Insights From a Contemporary TAVR Cohort During the COVID-19 Pandemic

Transfemoral TAVI With Dedicated Device for Severe Aortic Regurgitation in Patient With Left Ventricular Assist Device With Aortic Cusp Thrombus

IVUS-Directed Transfemoral Balloon Expandable TAVR in Pure Aortic Regurgitation Through an Endograft With Residual Aortic Dissection

TCT 705: Feasibility, Safety and Impact on Vascular Complication Management of Radial Use as an Ancillary Access During Transfemoral Transcatheter Aortic Valve Replacement: the TAVI-LITE Experience

TCT 113: (Pre)clinical Case Studies of J-Valve Transfemoral System for Treating Large Annulus Aortic Regurgitation

TCT 791: Concomitant transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve-in-ring (TMViR) procedure with transfemoral approach

Transcarotid Versus Transfemoral TAVR: Propensity-Matched Analysis of In-Hospital and 1-Year Clinical Outcomes

Intravascular Lithotripsy Assisted Percutaneous Transfemoral TAVR with Direct Puncture and Closure of Femoral Dacron Graft in a Nonagenarian with Prior Aortic Stent Graft

TCT 612: Apical VSD and Left Ventricular Dissection Following Transfemoral Transcatheter Aortic Valve Replacement

TCT 485: Do Manufacturer's Derived Recommendations Predict Vascular Complications During Transfemoral TAVI Approaches Using Default Proglide Strategy?

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation

The Anatomically “Correct” Transfemoral JenaValve TAVR System

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

New Generation Transcatheter Heart Valve for Severe Non-Calcified Aortic Regurgitation – The Transfemoral J-Valve System

Illustrative Cases

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content